GLP-1 Prescription Renewal: How It Works With Telehealth Programs

One of the most common questions from patients in their first few months of treatment is simple: what happens after the initial prescription ends? The answer is reassuring. Prescription renewal is built into the program structure.

Unlike a one-time telehealth visit where a provider writes a script and you never hear from them again, the Transformation Health program treats renewal as part of ongoing clinical care. Your provider doesn’t just refill your prescription on a set schedule. They review your progress, your labs, and your tolerance before deciding what the next phase looks like.

How the prescription period works

Compounded GLP-1 prescriptions are written for a defined period, commonly 3 to 6 months, with a specific dose escalation schedule.^[1] That schedule might look like this: week 1-4 at 0.25mg, week 5-8 at 0.5mg, week 9-12 at 1.0mg. The prescription is valid for the entire period, and your pharmacy prepares refills according to that timeline.

The monthly billing model means you’re paying every month for medication, labs, and provider oversight. But the prescription itself has an end date. When that date approaches, renewal requires a clinical decision from your provider, not an automatic refill.

This matters because it ensures someone is reviewing your progress at regular intervals. You are not just receiving medication in a box every month. A provider is checking whether the plan is working, whether you need to adjust, and whether continuing makes medical sense for you.

The renewal process: what the provider reviews

A prescription renewal is a brief clinical check-in. It typically happens asynchronously (you fill out a form or message your care team, the provider reviews and responds), though some state requirements may involve a synchronous call.

Here’s what the provider is looking at:

Your reported progress and side effects. How much weight have you lost? Are you experiencing gastrointestinal side effects? Are they manageable or are they limiting your daily life? Have there been any new health concerns or medications that might affect the prescription?

Lab results. If labs are due or have been recently drawn, the provider reviews them. A comprehensive metabolic panel (CMP) and hemoglobin A1c (HbA1c)^[2] check how your body is responding to the medication and whether your metabolic markers are moving in the right direction. Any abnormalities trigger a clinical conversation before the prescription is renewed.

Adherence to the escalation schedule. If you requested a dose increase earlier than planned, or if you skipped several doses, the provider takes that into account. The escalation schedule exists to minimize gastrointestinal side effects while maximizing therapeutic benefit.^[1] Rushing it does not improve outcomes.

Overall fit. Is this medication still appropriate for you? Are your goals still aligned? Has something changed about your health history that makes continuation risky?

Based on that review, the provider makes a determination: continue at the current dose, escalate to the next dose level, reduce the dose, or discontinue. If continuing is appropriate, a new prescription is issued.

Ongoing lab monitoring schedule

Lab work is part of the ongoing program cost. You are not paying per lab draw. Instead, routine labs are included in your monthly fee, and they happen on a predictable schedule.

At 3 months (first check-in). A comprehensive metabolic panel and HbA1c are drawn to assess metabolic response. If you started with additional baseline labs (lipid panel, thyroid function, liver enzymes), those may be repeated depending on your health history and initial results.

At 6 months. Another CMP and HbA1c, typically followed by a provider conversation about progress and whether dose escalation is appropriate.

At 12 months and annually thereafter. A more comprehensive monitoring panel to evaluate long-term metabolic health, kidney function, and other markers relevant to GLP-1 therapy.

Between these scheduled labs, additional testing may be ordered if you report side effects, if your progress stalls, or if you have a medical history that requires closer monitoring. Your provider determines the testing frequency based on your individual situation.

All lab work is processed at Quest Diagnostics or Labcorp near your location. You schedule the appointment at your convenience, the results are reviewed by your provider, and any findings are discussed in your next check-in.

Requesting a dose change

GLP-1 medications work through dose escalation. You do not start at the maximum dose and stay there forever. The standard escalation schedule is 4 weeks per dose level^[1], meaning you stay on each dose for approximately one month before moving to the next.

If you want to escalate the dose, you can request that through the patient portal or by messaging your care team. The provider reviews the request by looking at:

• How long you have been on your current dose
• Whether you are tolerating it well
• Whether your weight loss has plateaued or slowed
• What your recent labs show

If you have been on 0.5mg for only 2 weeks and request an increase to 1.0mg, the provider will likely recommend waiting. The standard escalation timeline exists for a reason. Rushing the schedule increases the risk of side effects^[1] without improving results.

If you have been on 1.0mg for 6 weeks, are tolerating it well, and your progress has plateaued, the provider is more likely to support escalation to 1.5mg.

If you want to reduce your dose because side effects are unmanageable, that conversation is equally important. Dose reduction is medically appropriate. The goal is to find the dose that gives you the best balance of appetite suppression and tolerability.

Either way, the provider has the final say. Dose changes are a clinical decision, not an automated process or a matter of preference alone.

Pausing or canceling your program

You can cancel or pause your Transformation Health program at any time. There is no minimum commitment, no early termination fee, and no complicated cancellation process.

If you cancel: Your medication shipments stop. The prescription is not renewed. You return to managing your weight without pharmaceutical support, just as you were before starting the program.

If you want to restart after a gap: You will need to complete a new intake form or an abbreviated re-evaluation with your provider. The reason is clinical, not punitive. If you were off semaglutide for 6 months, your body has adjusted to not having that medication in your system. Restarting at your previous dose may not be appropriate. Your provider may recommend re-titration starting at a lower dose, working back up to where you were, or possibly starting fresh depending on the length of the gap and your current health status.

The re-evaluation also gives your provider a chance to check whether anything has changed in your health history that might affect prescribing.

Transitioning to the Microdose program

Once you reach your goal weight, you have options. You can continue on your current dose indefinitely, reduce to a maintenance dose, or transition to our Microdose program.

The Microdose program is designed for patients who have achieved their weight loss goal and want to maintain it with a very low weekly dose (typically 0.05-0.1mg)^[4]. It costs $199/month, which is significantly less than the standard $249-339/month programs.

To qualify for Microdosing, you typically need:

• Prior GLP-1 experience (you cannot start directly on Microdose)
• A BMI of 20 or higher
• Provider approval based on your current health metrics and stability

Your provider will evaluate whether the transition makes sense for you. Microdosing is not right for everyone. Some patients prefer to maintain a higher dose, some find the very low dose ineffective for appetite control, and some have clinical reasons to stay on a higher dose.

If you are interested in learning more about maintenance and long-term weight management with GLP-1, read our guide to GLP-1 microdosing.

State-specific requirements for prescription renewal

Most states allow your provider to renew a prescription through an asynchronous review (your care team reviews your chart and issues a new prescription without a live call).

However, residents of Arkansas, DC, Delaware, Mississippi, New Mexico, Rhode Island, and West Virginia are required by state law^[3] to complete a live video consultation before any new prescription can be written. This includes prescription renewals.

If you live in one of these states, expect to schedule a brief video call with your provider at the time of renewal. This is not an extensive appointment. It typically takes 10-15 minutes. The provider reviews your progress, asks about side effects, checks your vital signs or weight if needed, and determines whether renewal is appropriate. After that call, the new prescription is issued.

For patients outside those states, your renewal can happen entirely through asynchronous communication. You fill out a check-in form, your provider reviews your charts and labs, and the new prescription is issued if appropriate.

Citations

[1] Wilding JPH, Batterham RL, Calanna S, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicine. 2021. https://pubmed.ncbi.nlm.nih.gov/33567185/

[2] American Diabetes Association. “Standards of Care in Diabetes.” Diabetes Care. 2024. https://diabetesjournals.org/care/article/47/Supplement_1/S295/153954

[3] State telehealth regulatory requirements for live consultation prior to prescription issuance. Applicable in AR, DC, DE, MS, NM, RI, and WV.

[4] Rubino DM, Greenway FL, Khalid U, et al. “Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults with Overweight or Obesity.” JAMA. 2021. https://pubmed.ncbi.nlm.nih.gov/33755728/